-transparent.png){kind=logo}
Idiopathic crescentic glomerulonephritis is associated with a 70% to 80% incidence of end-stage renal failure. Oral corticosteroid therapy in combination with immunosuppressive agents or anticoagulants has not altered the prognosis of this disease. We have seen five adults with idiopathic crescentic glomerulonephritis and treated them with intravenous methylprednisolone. Before therapy, the average serum creatinine concentration was 7.4 +/- 1.3 mg/dL (chi-square +/- SEM). This value declined to 2.0 +/- 0.48 mg/dL within 4 weeks. All patients continue to maintain stable renal function over an average follow-up period of 19 months (range 1.5 to 36 months). These data suggest that a prospective controlled trial of this therapy is warranted in the management of this entity.
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
January 1981,
Postgraduate medical journal,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
April 1991,
The Netherlands journal of medicine,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
March 1979,
The American journal of medicine,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
January 1984,
Scandinavian journal of rheumatology. Supplement,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
June 1992,
Nihon Jinzo Gakkai shi,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
January 1989,
American journal of nephrology,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
January 1982,
American journal of nephrology,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
April 1980,
Revista medica de Chile,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
April 1988,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
O Oredugba, and
D C Mazumdar, and
J S Meyer, and
H Lubowitz
January 1983,
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
